Milyrataj-IV 1mg Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Milrinone (1mg)
Overview Milyrataj-IV 1mg Injection
Milyrataj-IV Injection (1mg) provides short-term relief for heart failure symptoms. It's also indicated for patients experiencing reduced heart function post-cardiac surgery, improving cardiac output. Administration requires physician oversight, who will determine the appropriate dosage and treatment length. Close monitoring of blood pressure, heart rate, and ECG is standard practice until stabilization. Continue all other prescribed medications as directed, even during and after this injection therapy. Hypotension, headaches, arrhythmias, and tachycardia are potential side effects; report any concerning symptoms to your physician immediately. Precautions are necessary for certain patients; disclose any kidney conditions, pregnancy, breastfeeding, or other medications you're currently using to your doctor before treatment.
Uses of Milyrataj-IV 1mg Injection
Cardiac insufficiency
Major Benefits of Milyrataj-IV 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Milyrataj-IV 1mg Injection:
- Hypotension (low blood pressure)
- Headache
- Arrhythmia (irregular heartbeats)
- Tachycardia
How to use Milyrataj-IV 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Milyrataj-IV 1mg Injection works:
Milyrataj-IV 1mg injection is a medication that widens blood vessels. Its mechanism involves boosting cyclic AMP, a signaling molecule that promotes relaxation in smooth muscle tissue. This leads to improved blood flow to the heart by enlarging the blood vessels. The drug also exhibits anticoagulant effects.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Milyrataj-IV 1mg Injection is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Milyrataj-IV 1mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Intravenous Milyrataj, 1mg, appears safe for breastfeeding mothers. Available human data indicate minimal infant risk associated with its use.
DrivingCONSULT YOUR DOCTOR
The effect of Milyrataj-IV 1mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, the administration of Milyrataj-IV 1mg Injection requires careful consideration. A modified dosage of Milyrataj-IV 1mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The intravenous administration of 1mg Milyrataj is likely safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Milyrataj-IV 1mg Injection :
Omit any missed dose of Milyrataj-IV 1mg Injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Milyrataj-IV 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Bipyridine and Oligopyridine Derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | PDE3 inhibitors (heart failure) |
3,018 People bought this recently